Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.

L. Filik,H. Karakayalı,G. Moray,A. Dalgıç,R. Emiroğlu,N. Ozdemir,T. Colak,G. Gür,U. Yilmaz,M. Haberal
DOI: https://doi.org/10.1016/J.TRANSPROCEED.2005.12.047
IF: 1.014
2006-03-01
Transplantation Proceedings
Abstract:
What problem does this paper attempt to address?